Drug Trial Radar · NCT04237597
Pharmacokinetic Drug-Drug Interaction Study Between K-877 and CSG452 in Healthy Adult Volunteers
Last checked: Nov 19, 2026Latest source record: Sep 22, 2020 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
20
Actual
Start
Dec 17, 2019
Primary completion
Jan 31, 2020
Study completion Mar 4, 2020
Sponsor
- Lead sponsor
- Kowa Research Institute, Inc.Industry
- Sponsor type
- Industry
- First posted
- Jan 23, 2020
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 45 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
A study to compare the pharmacokinetic(s) of K-877 and CSG452 when each drug is administered alone and when both are administered together.
Conditions
- Healthy
Interventions
K-877Drug
K-877 tablets
CSG452Drug
CSG452 tablets
Primary outcomes
What the sponsor says the trial is designed to measure.
- Area under the plasma concentration versus time curve (AUC)Time frame: 0 to 24 hours
Locations
1 site in 1 country. Site status is shown where the registry gives one.
PPD Development. LP
Austin, Texas
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.